Hematology Highlights with Dr Joshua Richter

In this episode of Hematology Highlights, Dr Joshua Richter reviews major updates from the 2026 International Myeloma Society annual meeting, including the first definition of an MM cure, and what these advances mean for patients and practice.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, we return to our discussion on bridging therapy where Dr Joshua Richter walks through how to bet manage patients with multiple myeloma before CAR T-cell infusion, covering strategies to control disease, preserve T-cell fitness, and balance efficacy against toxicity so patients reach infusion safely.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of Hematology Highlights, Dr Joshua Richter speaks with Dr Larysa Sanchez about real-world treatment considerations for older adults with relapsed or refractory multiple myeloma.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr Joshua Richter reviews multiple myeloma treatment options for patients who are ineligible for or decline T-cell redirection therapy, including CAR T-cell therapy and bispecific antibodies. He discusses alternative therapies for relapsed or refractory multiple myeloma, including belantamab mafodotin, selinexor, venetoclax, cytotoxic chemotherapy, and emerging CELMoDs, with a focus on treatment sequencing, efficacy, and toxicity.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this inaugural episode of Hematology Unscripted, Dr Joshua Richter walks you through how to manage patients with multiple myeloma in the lead-up to CAR T-cell infusion, covering strategies to control disease, preserve T-cell fitness, and balance efficacy against toxicity so patients reach infusion safely.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.